Agile Therapeutics, Inc Earning Date (AGRX)

USA |NASDAQ |USD

AGRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 25, 2022 Jun 2022 - $-0.20 $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 25, 2022 Jun 2022 - - $1.19M

Agile Therapeutics, Inc's next earnings date is Monday, Jul 25, 2022 for the fiscal quarter ending Jun 2022.

AGRX Earnings Date & History Chart

AGRX Earnings & Revenue Forecast

AGRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.39 $-0.41 $-0.37

AGRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.39 $-0.45 $-0.59

AGRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $19.54M $15.04M $25.60M

AGRX Earnings Date & Revenue History

AGRX Earnings History

|
Show More
Show More

AGRX Revenue History

|
Show More
Show More

Agile Therapeutics, Inc Next Earnings Date & Report

AGRX Next Earnings Date & Report Preview: Jun 2022 (FQ)

AGRX's next earnings date is Monday, Jul 25, 2022 for the fiscal quarter ending Jun 30, 2022.

Agile Therapeutics, Inc Previous Earnings Dates & Reports

AGRX Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Agile Therapeutics, Inc's previous earnings date was May 12, 2022 for its fiscal quarter ended Mar 31, 2022.

AGRX's earnings per share (EPS) was $-0.20, beating the consensus analysts forecast of $-4.80 by 95.87%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -97.52%, and higher than the same period a year before (Mar 2021) by -0.95%.

AGRX Previous Earnings Date & Report Recap: Dec 2021 (FY)

Agile Therapeutics, Inc's previous annual earnings date was Mar 30, 2022 for its fiscal year ended Dec 31, 2021.

AGRX's earnings per share (EPS) was $-8.58, missing the consensus analysts forecast of $-0.73 by 1075.34% , and lower than the previous year's EPS (Dec 2020) by 1330.00%.

Revenues were $4.10M, better than the forecast of $4.10M by 0.02%, and up by 447.53% from previous year's revenue.

The company reported a net income of $-74.89M.

Agile Therapeutics, Inc reported a free cash flow of $-65.47M for its fiscal year, compared to $-47.66M a year ago.

The company ended the fiscal year with $17.79M in total debt, an increase of 7.71% compared to the previous year.